Akkermansia muciniphila inhibits nonalcoholic steatohepatitis by orchestrating TLR2-activated γδT17 cell and macrophage polarization

ABSTRACTCurrent evidence indicates that the next-generation probiotic Akkermansia muciniphila (A. muciniphila) has therapeutic potential for nonalcoholic fatty liver disease (NAFLD), especially its inflammatory stage known as nonalcoholic steatohepatitis (NASH). However, the mechanisms of A. mucinip...

Full description

Bibliographic Details
Main Authors: Yuqiu Han, Qi Ling, Li Wu, Xiaosen Wang, Zhifei Wang, Jun Chen, Zhipeng Zheng, Ziyuan Zhou, Longfei Jia, Lanjuan Li, Baohong Wang
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Gut Microbes
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/19490976.2023.2221485